| Independent Reports (Showing 1 to 10 of 17) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 9-Feb-10 | New Constructs, LLC | N/A | LGND: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 | $10 | View Abstract |
| 8-Feb-10 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 | $299 | View Abstract |
| 8-Feb-10 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 | $199 | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Value Graph: LIGAND PHARMACEU -- LGND | 1 | $4 | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ALKS , HITK , LGND , PANC , PPCO , UTHR -- DRUGS | 3 | $4 | View Abstract |
| 2-Feb-10 | EconomicInvestor | N/A | "The Economy Matters" Report for LGND: the economy's impact on LGND's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 | $15 | View Abstract |
| 31-Jan-10 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Ligand Pharmaceuticals Inc | 44 | $65 | View Abstract |
| 6-Jan-10 | Global Markets Direct | Global Markets Direct | Ligand Pharmaceuticals Incorporated Financial and Strategic Analysis Review | 23 | $300 | View Abstract |
| 5-Jan-10 | Zacks Investment Research Inc. | N/A | LIGAND PHARMA-B (LGND) Zacks Company Snapshot | 1 | $10 | View Abstract |
| 30-Mar-09 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | View Abstract |